Fund Holdings — Essex Woodlands Management, Inc.

Total Portfolio Value
$306.70M
Total Bought
$0
Total Sold
$0
Net Transaction
$0
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
BIOVENTUS(BVS)13,021,32413,021,324067,71174,87324.41%+7,162
VENUS CONCEPT, INC.1,089,1901,089,19007538530.28%+100
MEDICINOVA INC(MNOV)1,105,9411,105,94101,6041,5930.52%-11
REVANCE THERAPEUTICS INC457,085457,08502,2491,1750.38%-1,074
TELA BIO, INC.(TELA)4,110,7094,110,709023,30819,3206.30%-3,987
EYEPOINT PHARMACEUTICALS INC(EYPT)1,551,5211,551,521032,07013,4984.40%-18,572
MIMEDX GROUP, INC.(MDXG)28,195,24928,195,2490217,103195,39363.71%-21,710
Page 1 of 1
Essex Woodlands Management, Inc. — 13F Holdings — Q2 2024 | TickerTrail